The Food and Drug Administration is advising consumers not to purchase or use Umovy, a product promoted and sold for joint pain on various websites, including www.umovy-usa.com, and possibly in some retail stores.
Similar Posts
Meetings, Conferences, & Workshops | Drugs
Meetings, conferences, and workshops sponsored or co-sponsored by Center for Drug Evaluation and Research.FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
The FDA granted supplemental approval to Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the first FDA-approved treatment option for this indication.System Correction: IMPRIS Imaging Inc Issues Correction for IMRIS Neuro III-SV
IMPRIS corrects IMRIS Neuro III-SV models due to the potential of ice blockage in the helium venting pipeOnline Controlled Substances Summits
FDA hosted its fourth summit on June 8, 2023, as an integral part of FDA’s overall efforts to protect the public, including youth, from harm associated with drugs that have abuse potential.Platinum 69000 Rhino 69 contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Platinum 69000 Rhino 69, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Green Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings
Costa Mesa, California August 28, 2025 – Green Lumber Holding, LLC (“Green Lumber”) is alerting consumers that counterfeit products misrepresented as genuine Green Lumber have been identified and may pose health risks.